9th March 2022
Medscape have announced that both the EchoPen 6 and NovoPen Echo smart insulin pens will be available on the NHS. The pens automatically record insulin dosing information about each injection.
It's not yet clear how to request these, but they are likely to be prescribed by GPs soon.
More details about the pens is available here: https://www.novonordisk.com/our-products/smart-pens/novopen-6.html
______
10th March 2022
A new study has concluded that people with diabetes who develop foot ulcers are at much greater risk for hospitalisation and death from chronic health conditions. This underlies the importance of keeping our feet healthy and having healthy foot habits!
This week is actually National Feet Week in the UK and you can refer back to our Tips for Healthy Feet here: https://lovemylibre.com/blogs/news/diabetes-care-tips-healthy-feet
The report is available here: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(21)00542-8/fulltext
______
10th March 2022
Abbott have stated that Russia accounts for less than 2% of Abbott’s sales and Medtronic say that Russia and Ukraine represent less than 1% of 2021 sales.
Read our latest blog to discover how you can help Ukraine with medical supplies including insulin.
https://lovemylibre.com/blogs/news/help-ukraine-diabetes-supplies-medicines
______
14th March 2022
The much anticipated Dexcom G7 has now received a CE mark in Europe, meaning that it can be sold in the EU and UK. It's not yet on the market but it is expected to become available very soon, probably in the next couple of weeks.
In addition, the company stated that it "is also working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as possible."
Ahead of its launch we take a look at the features of the new-generation CGM in our new blog: Dexcom G7 - What to expect. click here.
Or read more in the press release here.
https://www.businesswire.com/news/home/20220309005998/en
______
17th March 2022
Abbott have announced that Libre 3 - real-time CGM without the need to scan - is now available in the UK.
However, you won't be able to get in through a GP on regular prescription as it's not available as an upgrade. It's only though Diabetes Healthcare teams ie. Hospital Consultants as you'll need to meet the NICE criteria on the NHS Supply Chain Network (see criteria here).
It's not clear if Libre 3 will appear on the FreeStyle Libre websitefor self-funders as it's not currently listed there.
There's more explanation about the Libre 3 launch in the press release here.
And, we have a explanation and details in our blog here.
______
25th March 2022
Ypsomed have partnered with CamDiab Ltd, the developer of CamAPS FX, an app to manage glucose levels via insulin pumps using an adaptive, hybrid closed-loop approach.
More details here
______
31st March 2022
Today is the day! NICE has updated the guidance for CGM use in England and all type 1s get access. No other criteria! Freestyle Libre or other CGM for all regardless of postcode and in preference to finger prick testing etc.
Offer adults with type 1 diabetes a choice of real-time continuous glucose monitoring (rtCGM) or intermittently scanned continuous glucose monitoring (isCGM, commonly referred to as 'flash'), based on their individual preferences, needs, characteristics, and the functionality of the devices available. See box 1 for examples of factors to consider as part of this discussion.
Read more in our blog here.
See official guidance NG17 here:
https://www.nice.org.uk/guidance/ng17/resources/type-1-diabetes-in-adults-diagnosis-and-management-pdf-1837276469701
______
1st April 2022
https://www.businesswire.com/news/home/20220401005092/en
______
Read February News: Click here.
Read January News: Click here.
